Targeting natural killer cells in cancer immunotherapy

Camille Guillerey, Nicholas D. Huntington, Mark J. Smyth

Research output: Contribution to journalReview ArticleResearchpeer-review

415 Citations (Scopus)


Alteration in the expression of cell-surface proteins is a common consequence of malignant transformation. Natural killer (NK) cells use an array of germline-encoded activating and inhibitory receptors that scan for altered protein-expression patterns, but tumor evasion of detection by the immune system is now recognized as one of the hallmarks of cancer. NK cells display rapid and potent immunity to metastasis or hematological cancers, and major efforts are now being undertaken to fully exploit NK cell anti-tumor properties in the clinic. Diverse approaches encompass the development of large-scale NK cell-expansion protocols for adoptive transfer, the establishment of a microenvironment favorable to NK cell activity, the redirection of NK cell activity against tumor cells and the release of inhibitory signals that limit NK cell function. In this Review we detail recent advances in NK cell-based immunotherapies and discuss the advantages and limitations of these strategies.

Original languageEnglish
Pages (from-to)1025-1036
Number of pages12
JournalNature Immunology
Issue number9
Publication statusPublished - 19 Aug 2016
Externally publishedYes

Cite this